GlobeNewswire

Bulletin from the Annual General Meeting of Formpipe Software AB held 30 June 2020

Share

N.B. English translation is for convenience purposes only

Allocation of the company’s results and discharge from liability

The Annual General Meeting (AGM) resolved, in accordance with the Board of Directors’ proposal, that SEK 0.60 per share shall be paid in dividend to the shareholders for the financial year 2019 and that the record date for the dividend shall be 2 July 2020. The dividend is expected to be distributed by Euroclear Sweden AB on 7 July 2020. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2019.

Election of Directors, Chairman of the Board, auditor and fees
The AGM resolved, in accordance with the Nomination Committees’ proposal, on the following:

That the remuneration is set to SEK 380,000 for the Chairman of the Board and SEK 190,000 each for the other members of the Board that are elected by the general meeting and are not employees in the company (i.e. a total remuneration to the Board of SEK 1 330,000).

That fees for the auditor are paid in accordance to invoice.

That the Board of Directors shall consist of six members, to re-elect Annikki Schaeferdiek, Åsa Landén Ericsson, Peter Lindström, Erik Syrén and Bo Nordlander as members of the Board, and to elect Martin Bjäringer as new member of the Board. Bo Nordlander was re-elected as the Chairman of the Board.

To, after completed procurement of auditor and in accordance with the Board of Directors’ recommendation, re-elect the auditing firm PricewaterhouseCoopers AB as the auditors of the company until the end of the AGM held in 2021. PricewaterhouseCoopers AB has announced that it intend to appoint the authorised auditor Aleksander Lyckow as the principal auditor.

Principles for appointment of the Nomination Committee and instruction to the Nomination Committee
The AGM resolved, in accordance with the Nomination Committees’ proposal, on principles for appointment of the Nomination Committee and instruction to the Nomination Committee.

The Board’s proposal to authorise the Board to resolve on issues of shares and convertibles
The AGM resolved, in accordance with the Board of Directors’ proposal, to authorise the Board to, within the limits of the articles of association, until the next AGM, on one or more occasions, resolve to issue new shares and/or convertibles. The Board is authorised to resolve on issues to the extent that the company's share capital may be increased by an amount equal to not more than 10 percent of the registered share capital at the time of the 2020 AGM.

The Board's proposal to authorise the Board to acquire and dispose of treasury shares
The AGM resolved, in accordance with the Board of Directors’ proposal, to authorise the Board, for the period until the next AGM, on one or more occasions, to acquire and/or dispose of the company's shares. Purchases may be made of as many shares that the company's holding does not exceed 10 percent of all shares of the company.

The Board’s proposal regarding guidelines for remuneration to the company’s senior executives
The AGM resolved, in accordance with the Board of Directors’ proposal, to adopt guidelines for remuneration to the company's senior executives. The guidelines mainly correspond to the previous guidelines with updates pursuant to new regulatory requirements.

The Board’s proposal regarding incentive program 2020/2023 through the issue of warrants
The AGM resolved, in accordance with the Board of Directors’ proposal, to implement incentive program 2020/2023 through a directed issue of a maximum of 500,000 warrants of series 2020/2023. Right to subscribe for the warrants shall without exemption belong to all employees of the company. Employees of the company shall be guaranteed allotment of not less than 2,000 warrants per subscriber. The warrants are issued at a price equal to market value of the warrants, calculated by using the Black & Scholes warrant valuation model. Each warrant entails a right to subscribe for one new share in the company. The subscription price when exercising a warrant shall be 120 percent of the average volume weighted price paid for the company’s share on Nasdaq Stockholm during the period from 22 June 2020 up to and including 29 June 2020. The warrants may be exercised by application for subscription for new shares during the period from and including 15 May 2023 up to and including 26 May 2023. The maximum dilution effect of incentive program 2020/2023 is estimated to not more than 0.9 percent of the total number of shares and votes in the company, provided that the warrants are fully subscribed for and exercised.

The Board’s proposal to authorise the Board to re-purchase warrants
The AGM resolved, in accordance with the Board of Directors’ proposal, to authorise the Board, during the period until the next AGM, on one or more occasions, to resolve to repurchase, at the current market price, up to 50 percent of the total of 500,000 warrants issued as resolved by the AGM 2018. The warrants that are subject to the resolution, entitles its holder to subscribe for new shares in the company for SEK 17.90 per share during the period from and including 10 May 2021 up to and including 21 May 2021. A repurchase of the warrants shall be conditional upon each individual warrant holder who wish to have warrants repurchased using an equivalent amount of the invested warrants to subscribe for new shares.

The Board’s proposed resolution regarding amendment of the articles of association
The AGM resolved, in accordance with the Board of Directors’ proposal, to amend § 9 in the company’s articles of association. The amendment takes into account expected future legislation regarding the record date for participation at general meetings.

For additional information, contact:
Christian Sundin, President and CEO of Formpipe, +46 705 67 73 85
Bo Nordlander, Chairman of the Board, +46 546 63 10

______________________________________________________

This is a translation of the original Swedish version. In the event of any discrepancies between the two versions, the original Swedish version shall take precedence.

The information was submitted for publication through the agency of the contact persons set out above, at 12:00 CET June 30, 2020.

Formpipe develops ECM products and solutions for structuring information and supplies them to major companies, authorities and organisations. ECM products help organisations to capture, manage and distribute information, and to place it in context. The company’s software helps improve efficiency, cut costs and reduce risk exposure. Formpipe was founded in 2004 and has offices in Sweden, Denmark, United Kingdom, The Netherlands, Germany and USA. The Formpipe share is listed on Nasdaq Stockholm.

Attachment

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

AND (Ticker: AND.AS) intends to rebrand the company22.9.2020 18:05:00 CESTPress release

Supporting the turnaround and the new strategic direction of the company Capelle aan den IJssel, the Netherlands, 22 September 2020 - AND is happy to announce that it intends to change the company name and refresh its branding in Q4 2020. This change is designed to highlight the company’s new strategic direction as well as support and strengthen the transformation into a subscription based provider of premium location aware content and services. As announced on August 12th, the turnaround strategy has already delivered 22% revenue growth in the first half of 2020. AND believes the new company name and branding will help to drive continued revenue growth and put location-intelligence squarely at the center of the company’s profile. Further announcements will follow in Q4 2020. Ends About AND AND is an innovative location-aware content and service provider. Our focus is to create and deliver market leading, relevant, innovative and tailored content which fosters a safer and more sustaina

Wolters Kluwer Completes Divestment of ComplyTrack22.9.2020 17:30:00 CESTPress release

Wolters Kluwer Completes Divestment of ComplyTrack September 22, 2020 - Wolters Kluwer announces today that it has completed the divestment of ComplyTrack to symplr, as originally announced on September 8, 2020. About Wolters Kluwer Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services. Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolt

Joint Stock Company “Olainfarm” Extraordinary Shareholders Meeting on September 22, 2020 at 15.00  has not been held due to lack of quorum22.9.2020 14:20:00 CESTPress release

Joint Stock Company “Olainfarm” Extraordinary Shareholders Meeting on September 22, 2020 at 15.00 has not been held due to lack of quorum Joint Stock Company “Olainfarm” Management Board informs that for the Extraordinary Shareholders Meeting on September 22, 2020 at 15.00 pm shareholders who in total represented 3 877 425 voting shares or 27.53% of voting capital were registered, therefore shareholders' meeting did not take place due to lack of quorum. Olaine, September 22, 2020 Additional information: Jānis Dubrovskis Investor Relations Advisor of JSC Olainfarm Ph.: +371 29178878 janis.dubrovskis@olainfarm.com

RESOLUTIONS of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on September 22, 202022.9.2020 13:05:00 CESTPress release

RESOLUTIONS of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on September 22, 2020 Report of the Board on results of operations in 2019. Resolution: To take notice of the Report of the Board of the JSC “Olainfarm” on results of operations in 2019. Voting results: decision is taken with the required majority of votes. Report of the Council on results of operations in 2019. Resolution: To take notice of the Report of the Council of the JSC “Olainfarm” on results of operations in 2019. Voting results: decision is taken with the required majority of votes. Approval of the JSC “Olainfarm” Consolidated Annual Report for 2019. Resolution: To approve the Consolidated and Parent Company’s Annual Report of JSC „Olainfarm” for 2019 with profit in amount of EUR 22 239 000,00. Voting results: decision is taken with the required majority of votes. Distribution of profit of 2019. Resolution: 4.1. To pay dividends to the shareholders of the Joint Stock Company" Olainfarm " i

ProMIS Neurosciences to develop multivalent vaccine for Alzheimer’s disease22.9.2020 12:30:10 CESTPress release

Potential vaccine to incorporate ProMIS proprietary peptide antigens; early in vivo preclinical data demonstrate neuronal protection and improvement in cognitive deficits TORONTO and CAMBRIDGE, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today initiation of a program to construct and test a multivalent peptide vaccine for Alzheimer’s disease (AD). The critical first steps in vaccine development will be carried out by VIDO-InterVac, a global leader in vaccine research and development. Recent progress in the development of blood-based biomarkers for neurodegeneration is enabling increased screening to diagnose and identify individuals at risk of developing AD. A vaccine capable of inducing an effective antibody response against amyloid-beta toxic oligom

AIR Worldwide Releases Updated Multiple Peril Crop Insurance Model for China22.9.2020 12:11:10 CESTPress release

Boston, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Catastrophe risk modeling firm AIR Worldwide (AIR) today announced that it released an updated Multiple Peril Crop Insurance (MPCI) Model for China to support probabilistic assessments for five newly modeled crop lines of business and a newly modeled sub-peril. This update also includes a new livestock module that adds six additional lines of business and two new sub-perils. AIR Worldwide is a Verisk (Nasdaq:VRSK) business. “In 2011, AIR leveraged its considerable experience and success in modeling MPCI portfolios in the United States to develop a model for mainland China. Since then, the model has been updated several times to keep it current with the fast-changing Chinese agricultural insurance market,” said Dr. Jeff Amthor, assistant vice president, AIR Worldwide. “The MPCI Model for China captures the severity, frequency, and location of drought, flood, wind, frost, and heat events nationwide, covering over 90% of the weather-related crop